{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:13:34Z","timestamp":1789578814660,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurgie"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00104-025-02443-4","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T09:14:07Z","timestamp":1769678047000},"page":"351-357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neue bildgebende Verfahren zur Differenzialdiagnose von Nebennierentumoren, Ph\u00e4ochromozytomen und Paragangliomen","Novel imaging techniques for the differential diagnosis of adrenal tumors, pheochromocytomas and paragangliomas"],"prefix":"10.1007","volume":"97","author":[{"given":"Friederike","family":"Eilsberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Luster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"issue":"69","key":"2443_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.nucmedbio.2018.11.002","volume":"68","author":"S Bongarzone","year":"2019","unstructured":"Bongarzone\u00a0S, Basagni\u00a0F, Sementa\u00a0T et\u00a0al (2019) Development of [(18)F]FAMTO: A\u00a0novel fluorine-18 labelled positron emission tomography (PET) radiotracer for imaging CYP11B1 and CYP11B2 enzymes in adrenal glands. Nucl Med Biol 68(69):14\u201321","journal-title":"Nucl Med Biol"},{"key":"2443_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1210\/jc.2011-1537","volume":"97","author":"TJ Burton","year":"2012","unstructured":"Burton\u00a0TJ, Mackenzie\u00a0IS, Balan\u00a0K et\u00a0al (2012) Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn\u2019s adenomas. J\u00a0Clin Endocrinol Metab 97:100\u2013109","journal-title":"J Clin Endocrinol Metab"},{"key":"2443_CR3","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1442-2042.2011.02836.x","volume":"18","author":"C Cao","year":"2011","unstructured":"Cao\u00a0C, Yang\u00a0X, Li\u00a0L et\u00a0al (2011) Increased expression of CYP17 and CYP11B1 in subclinical Cushing\u2019s syndrome due to adrenal adenomas. Int J Urol 18:691\u2013696","journal-title":"Int J Urol"},{"key":"2443_CR4","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2967\/jnumed.120.259689","volume":"62","author":"JA Carrasquillo","year":"2021","unstructured":"Carrasquillo\u00a0JA, Chen\u00a0CC, Jha\u00a0A et\u00a0al (2021) Imaging of Pheochromocytoma and Paraganglioma. J\u00a0Nucl Med 62:1033\u20131042","journal-title":"J Nucl Med"},{"key":"2443_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/RLU.0000000000004244","volume":"47","author":"J Ding","year":"2022","unstructured":"Ding\u00a0J, Tong\u00a0A, Hacker\u00a0M et\u00a0al (2022) Usefulness of 68\u202fGa-Pentixafor PET\/CT on Diagnosis and Management of Cushing Syndrome. Clin Nucl Med 47:669\u2013676","journal-title":"Clin Nucl Med"},{"key":"2443_CR6","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-18-0608","volume":"179","author":"M Fassnacht","year":"2018","unstructured":"Fassnacht\u00a0M, Dekkers\u00a0OM, Else\u00a0T et\u00a0al (2018) European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 179:G1\u2013g46","journal-title":"Eur J Endocrinol"},{"key":"2443_CR7","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1210\/jc.2017-00254","volume":"102","author":"C Guerin","year":"2017","unstructured":"Guerin\u00a0C, Pattou\u00a0F, Brunaud\u00a0L et\u00a0al (2017) Performance of 18F-FDG PET\/CT in the Characterization of Adrenal Masses in Noncancer Patients: A\u00a0Prospective Study. J\u00a0Clin Endocrinol Metab 102:2465\u20132472","journal-title":"J Clin Endocrinol Metab"},{"key":"2443_CR8","doi-asserted-by":"publisher","first-page":"105735","DOI":"10.1016\/j.ebiom.2025.105735","volume":"116","author":"S Hahner","year":"2025","unstructured":"Hahner\u00a0S, Hartrampf\u00a0P, Beuschlein\u00a0F et\u00a0al (2025) Combined [(18)F]Fluorodeoxyglucose PET and [(123)I]Iodometomidate-SPECT for diagnostic evaluation of indeterminate adrenal neoplasias-the cross-sectional diagnostic test accuracy study FAMIAN. eBioMedicine 116:105735","journal-title":"eBioMedicine"},{"key":"2443_CR9","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1210\/jc.2012-3045","volume":"98","author":"S Hahner","year":"2013","unstructured":"Hahner\u00a0S, Kreissl\u00a0MC, Fassnacht\u00a0M et\u00a0al (2013) Functional characterization of adrenal lesions using [123I]IMTO-SPECT\/CT. J\u00a0Clin Endocrinol Metab 98:1508\u20131518","journal-title":"J Clin Endocrinol Metab"},{"key":"2443_CR10","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1210\/jc.2008-0050","volume":"93","author":"S Hahner","year":"2008","unstructured":"Hahner\u00a0S, Stuermer\u00a0A, Kreissl\u00a0M et\u00a0al (2008) 123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. J\u00a0Clin Endocrinol Metab 93:2358\u20132365","journal-title":"J Clin Endocrinol Metab"},{"key":"2443_CR11","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.7150\/thno.100848","volume":"14","author":"L He","year":"2024","unstructured":"He\u00a0L, Yang\u00a0Y, Cao\u00a0X et\u00a0al (2024) (18)F]AlF-NOTA-pentixather PET\/CT of CXCR4 in patients with suspected primary hyperaldosteronism. Theranostics 14:7281\u20137291","journal-title":"Theranostics"},{"key":"2443_CR12","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1210\/jc.2005-2273","volume":"91","author":"J Hennings","year":"2006","unstructured":"Hennings\u00a0J, Lindhe\u00a0O, Bergstr\u00f6m\u00a0M et\u00a0al (2006) 11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings. J\u00a0Clin Endocrinol Metab 91:1410\u20131414","journal-title":"J Clin Endocrinol Metab"},{"key":"2443_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2967\/jnumed.120.248021","volume":"62","author":"L Kessler","year":"2021","unstructured":"Kessler\u00a0L, Schlitter\u00a0AM, Kr\u00f6nke\u00a0M et\u00a0al (2021) First Experience Using (18)F-Flubrobenguane PET Imaging in Patients with Suspected Pheochromocytoma or Paraganglioma. J\u00a0Nucl Med 62:479\u2013485","journal-title":"J Nucl Med"},{"key":"2443_CR14","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1210\/jc.2012-3261","volume":"98","author":"MC Kreissl","year":"2013","unstructured":"Kreissl\u00a0MC, Schirbel\u00a0A, Fassnacht\u00a0M et\u00a0al (2013) 123I]Iodometomidate imaging in adrenocortical carcinoma. J\u00a0Clin Endocrinol Metab 98:2755\u20132764","journal-title":"J Clin Endocrinol Metab"},{"key":"2443_CR15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1097\/RLU.0000000000006014","volume":"50","author":"T Long","year":"2025","unstructured":"Long\u00a0T, Liu\u00a0G, Zhou\u00a0M et\u00a0al (2025) First-in-Human Evaluation of [ 18\u202fF]AldoView: A\u00a0Highly Selective PET Tracer for Aldosterone Synthase Imaging in Primary Aldosteronism. Clin Nucl Med 50:847\u2013855","journal-title":"Clin Nucl Med"},{"key":"2443_CR16","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.21037\/qims-20-875","volume":"11","author":"G Ma","year":"2021","unstructured":"Ma\u00a0G, Zhang\u00a0X, Wang\u00a0M et\u00a0al (2021) Role of (18)F-FDG PET\/CT in the differential diagnosis of primary benign and malignant unilateral adrenal tumors. Quant Imaging Med Surg 11:2013\u20132018","journal-title":"Quant Imaging Med Surg"},{"key":"2443_CR17","doi-asserted-by":"crossref","unstructured":"Mendichovszky IA, Powlson AS, Manavaki R et\u00a0al (2016) Targeted Molecular Imaging in Adrenal Disease-An Emerging Role for Metomidate PET-CT. Diagnostics (basel) 6:","DOI":"10.3390\/diagnostics6040042"},{"key":"2443_CR18","first-page":"32","volume":"47","author":"U Metser","year":"2006","unstructured":"Metser\u00a0U, Miller\u00a0E, Lerman\u00a0H et\u00a0al (2006) 18F-FDG PET\/CT in the evaluation of adrenal masses. J\u00a0Nucl Med 47:32\u201337","journal-title":"J Nucl Med"},{"key":"2443_CR19","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1007\/s00268-010-0576-3","volume":"34","author":"ML Nunes","year":"2010","unstructured":"Nunes\u00a0ML, Rault\u00a0A, Teynie\u00a0J et\u00a0al (2010) 18F-FDG PET for the identification of adrenocortical carcinomas among indeterminate adrenal tumors at computed tomography scanning. World J Surg 34:1506\u20131510","journal-title":"World J Surg"},{"key":"2443_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00268-015-3242-y","volume":"40","author":"D Patel","year":"2016","unstructured":"Patel\u00a0D, Gara\u00a0SK, Ellis\u00a0RJ et\u00a0al (2016) FDG PET\/CT Scan and Functional Adrenal Tumors: A\u00a0Pilot Study for Lateralization. World J Surg 40:683\u2013689","journal-title":"World J Surg"},{"key":"2443_CR21","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1097\/HJH.0000000000003132","volume":"40","author":"TH Puar","year":"2022","unstructured":"Puar\u00a0TH, Khoo\u00a0CM, Tan\u00a0CJ et\u00a0al (2022) 11C-Metomidate PET-CT versus adrenal vein sampling to subtype primary aldosteronism: a\u00a0prospective clinical trial. J\u00a0Hypertens 40:1179\u20131188","journal-title":"J Hypertens"},{"key":"2443_CR22","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1210\/clinem\/dgad138","volume":"108","author":"M Schaafsma","year":"2023","unstructured":"Schaafsma\u00a0M, Berends\u00a0AMA, Links\u00a0TP et\u00a0al (2023) The Diagnostic Value of 18F-FDG PET\/CT Scan in Characterizing Adrenal Tumors. J\u00a0Clin Endocrinol Metab 108:2435\u20132445","journal-title":"J Clin Endocrinol Metab"},{"key":"2443_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13550-025-01309-4","volume":"15","author":"Z Shu","year":"2025","unstructured":"Shu\u00a0Z, He\u00a0Y, Long\u00a0T et\u00a0al (2025) Is CXCR4-targeted (68)Ga-pentixafor PET\/CT a\u00a0reliable AVS-free modality for surgical decision-making and prognostic prediction in primary aldosteronism with bilateral adrenal lesions? EJNMMI Res 15:111","journal-title":"EJNMMI Res"},{"key":"2443_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13550-024-01109-2","volume":"14","author":"I Silins","year":"2024","unstructured":"Silins\u00a0I, Moreno\u00a0A, Wall\u00a0A et\u00a0al (2024) Radiation dosimetry of para-chloro-2-[(18)F]fluoroethyl-etomidate: a\u00a0PET tracer for adrenocortical imaging. EJNMMI Res 14:48","journal-title":"EJNMMI Res"},{"key":"2443_CR25","unstructured":"Unter der Federf\u00fchrenden Fachgesellschaft der Deutschen Gesellschaft f\u00fcr Allgemein- und Viszeralchirurgie e.\u202fV. (DGAV) und Beteiligung von DGE, DGN, DGP, CAEK, AIO, DGR, Netzwerk Hypophysen- und Nebennierenerkrankungen: S2k-Leitlinie Operative Therapie von Nebennierentumoren. Registernummer 088 - 008, Stand 17. Dez. 2017"},{"key":"2443_CR26","doi-asserted-by":"publisher","first-page":"869","DOI":"10.2967\/jnumed.121.262797","volume":"63","author":"M Weber","year":"2022","unstructured":"Weber\u00a0M, Schmitz\u00a0J, Maric\u00a0I et\u00a0al (2022) Diagnostic Performance of (124)I-Metaiodobenzylguanidine PET\/CT in Patients with Pheochromocytoma. J\u00a0Nucl Med 63:869\u2013874","journal-title":"J Nucl Med"},{"key":"2443_CR27","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.2967\/jnumed.108.058701","volume":"50","author":"GA Wiseman","year":"2009","unstructured":"Wiseman\u00a0GA, Pacak\u00a0K, O\u2019dorisio\u00a0MS et\u00a0al (2009) Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a\u00a0prospective multicenter trial. J\u00a0Nucl Med 50:1448\u20131454","journal-title":"J Nucl Med"},{"key":"2443_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41591-022-02114-5","volume":"29","author":"X Wu","year":"2023","unstructured":"Wu\u00a0X, Senanayake\u00a0R, Goodchild\u00a0E et\u00a0al (2023) (11)C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a\u00a0prospective, within-patient trial. Nat Med 29:190\u2013202","journal-title":"Nat Med"},{"key":"2443_CR29","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11307-024-01976-0","volume":"27","author":"T Yi","year":"2025","unstructured":"Yi\u00a0T, Lu\u00a0D, Cui\u00a0Y et\u00a0al (2025) (68)Ga-pentixafor PET\/CT Is a\u00a0Supplementary Method for Primary Aldosteronism Subtyping Compared with Adrenal Vein Sampling. Mol Imaging Biol 27:142\u2013150","journal-title":"Mol Imaging Biol"},{"key":"2443_CR30","doi-asserted-by":"crossref","unstructured":"Zheng G, Liu S, Gao Y et\u00a0al (2025) 68Ga-pentixafor PET\/CT versus adrenal venous sampling in guiding surgical management for primary aldosteronism: a\u00a0prospective cohort study on postoperative outcomes. Int J Surg","DOI":"10.1097\/JS9.0000000000003483"}],"container-title":["Die Chirurgie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-025-02443-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00104-025-02443-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-025-02443-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T13:48:45Z","timestamp":1776952125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00104-025-02443-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2443"],"URL":"https:\/\/doi.org\/10.1007\/s00104-025-02443-4","relation":{},"ISSN":["2731-6971","2731-698X"],"issn-type":[{"value":"2731-6971","type":"print"},{"value":"2731-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F.\u00a0Eilsberger, K.\u00a0Michalski und M.\u00a0Luster geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}